The 88-year-old patient was originally not seen as a viable candidate for TAVR or surgery.

SAVR may be even safer for low-risk patients than previously believed, according to new research published in the Journal of Thoracic and Cardiovascular Surgery. What does this tell us about patient care going forward?

Cardiologists and other physicians have always believed cardiac transthyretin amyloidosis, a progressive heart condition associated with a high mortality rate, was irreversible. Now, though, new evidence suggests that there may be hope. 

This latest acquisition continues what has been a busy year for Cardiovascular Associates of America. 

The North Carolina physician allegedly performed unnecessary atherectomy procedures to treat minor blockages in the leg arteries of multiple patients.

Multiple medical devices used during cardiopulmonary bypass and extracorporeal membrane oxygenation procedures have been voluntarily recalled due to issues with their packaging.

The new device was designed to remove thrombi and emboli from peripheral arteries ranging from 2 to 4 mm. 

A law firm hired to investigate the situation reviewed more than 300,000 pages of documents and conducted more than 250 hours of interviews. 

The cardiologist's bond has been set at $5 million. He will appear in court next on June 22 for a preliminary hearing.

Researchers compared minithoracotomy, a minimally invasive procedure for treating degenerative mitral regurgitation, with conventional surgery, sharing their findings in JAMA. The research was previously presented as a late-breaking study at ACC.23.